Ortin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SHARVARI SWAPNIL SHINDEDesignation :- Company Secretary and Compliance Officer Ortin Laboratories Ltd - 539287 - Closure of Trading Window
The trading window for dealing in the securities of the Company will remain closed from 31st March, 2019 till 48 hours after the declaration of financial results for the quarter ended and year ended 31.03.2019, for all designated persons, their immediate relatives and all connected persons covered under the Company's Code of Conduct. Ortin Laboratories Ltd - 539287 - Intimation U/R 8(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Company's Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information has been amended in accordance with the provisions of the SEBI (prohibition of Insider Trading) (Amended) Regulations, 2018. Ortin Laboratories Ltd - 539287 - Outcome Of Board Meeting Held On 14.02.2019
With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of Ortin Laboratories Limited held on Thursday, 14.02.2019 at 5:00 pm. at the registered office of the company at D. No: 3-4-512/35 (43/4RT), Opp: Barkatpura Park, Barkatpura, Hyderabad-500027, TeIangana, the un-audited financial results for the quarter ended 31.12.2018 along with Limited Review Report was considered and approved: Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31.12.2018
Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve Un-audited financial results for the quarter ended 31.12.2018 Ortin Laboratories Ltd - 539287 - Shareholding for the Period Ended December 31, 2018
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here Ortin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MURALI KRISHNA MURTHY SANKA Designation :- Director Un-Audited Financial Results For The Quarter Ended 30.09.2018
Un-audited Financial results for the quarter ended 30.09.2018 